All News
Risk Factors for Rheumatoid Arthritis-associated Interstitial Lung Disease
Sparks and colleagues have published a matched cohort analysis demonstrating risk factors that may augment the risk of rheumatoid arthritis (RA)-associated interstitial lung disease (ILD), especially the combination of obesity, high CRP, high MD-HAQ and >30 pack-year smoking h
Read ArticleNSAID Safety with COVID-19 Infection
NSAIDs do not affect COVID outcomes; here we are nearly 16 months into the pandemic, and this is the common sense conclusion of a recent trial published in Lancet Rheumatology.
Read ArticleInsurers Bet Big on Bribing Patients
Last month, psoriasis patients covered by Cigna received a curious letter from the insurance giant's pharmacy management division.
Read ArticleAURORA-1: Voclosporin Efficacy in Lupus Nephritis
Lancet has published the results of the AURORA-1 trial, wherein the calcineurin inhibitor, voclosporin, was tested in a placebo controlled trial of lupus nephritis and shown to be effective at inducing a complete renal response.
Read Article
Links:

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:


Links:

Links:

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:

Links:


Links:

Links:
Dr. John Cush RheumNow ( View Tweet)

Links: